Nivagen Pharmaceuticals Inc. is recalling 2,328 bottles of Atorvastatin Calcium Tablets (40 mg), a prescription medication used to manage cholesterol. The recall was issued after a single 400 mg tablet of Carbamazepine Extended-Release, an anticonvulsant medication, was discovered inside a 1000-count bottle of the Atorvastatin. Consumers who inadvertently take the wrong medication may experience serious side effects or drug interactions.
Taking Carbamazepine instead of the prescribed Atorvastatin can cause significant adverse health effects, including dizziness, drowsiness, nausea, and potential interactions with other medications. Additionally, missing a dose of prescribed Atorvastatin could lead to poorly managed cholesterol levels.
You have 2 options:
Manufactured for Nivagen Pharmaceuticals by Umedica Laboratories Pvt Ltd.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.